VAERS reports by lot

Moderna COVID-19 lot 04B21A: VAERS reports

30 VAERS reports list lot 04B21A as a Moderna COVID-19 vaccine, received between 2021-04-14 and 2022-09-19. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
30
Reports
10%
Marked serious
1
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3323%
Musculoskeletal2215%
Cardiac / Cardiovascular1913%
Neurological1812%
Injection-site / Local reaction1410%
Gastrointestinal139%
Allergic / Anaphylactic107%
Respiratory53%
Dermatological (non-injection-site)43%
Thrombotic / Hematological32%
Autoimmune / Immune-mediated32%

Where reports came from

U.S. state of the reporter, where given (top 12).

Virginia4
Pennsylvania4
California3
Texas3
Massachusetts3
Delaware1
Washington1
Florida1
New York1
Maryland1
South Carolina1
Kansas1

Reports by month received

2021-047
2021-056
2021-0810
2021-121
2022-013
2022-021
2022-041
2022-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.